Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CP-870,893 |
Synonyms | |
Therapy Description |
CP-870,893 is a monoclonal antibody that binds CD40 and acts as an agonist, which potentially results in enhanced immune response and tumor growth inhibition (PMID: 21479995, PMID: 30288340). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CP-870,893 | CP-870893 | CD40 Antibody 14 | CP-870,893 is a monoclonal antibody that binds CD40 and acts as an agonist, which potentially results in enhanced immune response and tumor growth inhibition (PMID: 21479995, PMID: 30288340). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|